Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between with United ...

A five-item tool using spirometry and basic clinical data may predict recurrent tuberculosis with moderate accuracy, helping ...

Gilead Sciences, Inc. (GILD) on Wednesday announced a strategic partnership agreement with the Global Fund to combat AIDS, ...

Humans have been getting infected by ancient bacteria and viruses for at least 37,000 years. Now, for the first time, ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalised plans to ...

US antivirals specialist Gilead Sciences today announced a strategic partnership agreement with the Global Fund to Fight AIDS ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Kaso sa Tuberculosis sa Davao Region, misaka og kapin 20% sa 2024 itandi niadtong 2023, sumala sa DOH-11 See what's fresh ...

To further strengthen the fight against tuberculosis, the Union Health Ministry will soon procure 1,500 more handheld X-ray machines to facilitate large-scale screening and early detection of cases, ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...